Literature DB >> 22000304

Elevated concentrations of inflammation-related proteins in postnatal blood predict severe developmental delay at 2 years of age in extremely preterm infants.

T Michael O'Shea1, Elizabeth N Allred, Karl C K Kuban, Olaf Dammann, Nigel Paneth, Raina Fichorova, Deborah Hirtz, Alan Leviton.   

Abstract

OBJECTIVE: To evaluate the hypothesis that elevated levels of inflammation-related proteins in early postnatal blood predict impaired mental and motor development in extremely preterm infants. STUDY
DESIGN: We measured concentrations of 25 inflammation-related proteins in blood collected on postnatal days 1, 7, and 14 from 939 infants born before 28 weeks gestation. An elevated level was defined as a concentration in the highest quartile for gestational age and day of blood collection. We identified impaired development at age 24 months using the Bayley Scales of Infant Development, Second Edition. The primary outcomes were scores on the Mental Scale or the Motor Scale of <55 (more than 3 SDs below the mean).
RESULTS: For 17 of the 25 inflammation-related proteins, 1 or more statistically significant associations (P<.01) was found between an elevated blood level of the protein and a developmental impairment. Elevations on multiple days were more often associated with developmental impairment than were elevations present for only 1 day. The highest number of predictive elevations was found in day-14 blood.
CONCLUSION: In extremely preterm infants, elevated levels of inflammation-related proteins in blood collected on postnatal days 7 and 14, especially when sustained, are associated with impaired mental and motor development at age 2 years. Copyright Â
© 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22000304      PMCID: PMC3279610          DOI: 10.1016/j.jpeds.2011.08.069

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  27 in total

Review 1.  Lipopolysaccharide-induced inflammation and perinatal brain injury.

Authors:  Xiaoyang Wang; Catherine I Rousset; Henrik Hagberg; Carina Mallard
Journal:  Semin Fetal Neonatal Med       Date:  2006-06-21       Impact factor: 3.926

2.  Development and reliability of a system to classify gross motor function in children with cerebral palsy.

Authors:  R Palisano; P Rosenbaum; S Walter; D Russell; E Wood; B Galuppi
Journal:  Dev Med Child Neurol       Date:  1997-04       Impact factor: 5.449

Review 3.  The adaptive immune response in neonatal cerebral white matter damage.

Authors:  Alan Leviton; Olaf Dammann; Scott K Durum
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

4.  The relationship between early concentrations of 25 blood proteins and cerebral white matter injury in preterm newborns: the ELGAN study.

Authors:  Alan Leviton; Karl Kuban; T Michael O'Shea; Nigel Paneth; Raina Fichorova; Elizabeth N Allred; Olaf Dammann
Journal:  J Pediatr       Date:  2011-01-15       Impact factor: 4.406

5.  Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis.

Authors:  M B Edelson; C E Bagwell; H J Rozycki
Journal:  Pediatrics       Date:  1999-04       Impact factor: 7.124

6.  Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans.

Authors:  Shefali Talwar; Peter J Munson; Jennifer Barb; Carmen Fiuza; Anadel Pilar Cintron; Carolea Logun; Margaret Tropea; Sameena Khan; Debra Reda; James H Shelhamer; Robert L Danner; Anthony F Suffredini
Journal:  Physiol Genomics       Date:  2006-01-10       Impact factor: 3.107

Review 7.  Brain damage in preterm newborns: might enhancement of developmentally regulated endogenous protection open a door for prevention?

Authors:  O Dammann; A Leviton
Journal:  Pediatrics       Date:  1999-09       Impact factor: 7.124

8.  Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain.

Authors:  Saskia Eklind; Carina Mallard; Pernilla Arvidsson; Henrik Hagberg
Journal:  Pediatr Res       Date:  2005-05-05       Impact factor: 3.756

9.  Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis.

Authors:  Susan R Hintz; Douglas E Kendrick; Barbara J Stoll; Betty R Vohr; Avroy A Fanaroff; Edward F Donovan; W Kenneth Poole; Martin L Blakely; Linda Wright; Rosemary Higgins
Journal:  Pediatrics       Date:  2005-03       Impact factor: 7.124

Review 10.  Inflammatory brain damage in preterm newborns--dry numbers, wet lab, and causal inferences.

Authors:  Olaf Dammann; Alan Leviton
Journal:  Early Hum Dev       Date:  2004-08       Impact factor: 2.079

View more
  77 in total

1.  Neutralizing anti-interleukin-1β antibodies reduce ischemia-related interleukin-1β transport across the blood-brain barrier in fetal sheep.

Authors:  Aparna Patra; Xiaodi Chen; Grazyna B Sadowska; Jiyong Zhang; Yow-Pin Lim; James F Padbury; William A Banks; Barbara S Stonestreet
Journal:  Neuroscience       Date:  2017-01-09       Impact factor: 3.590

Review 2.  Microorganisms in the Placenta: Links to Early-Life Inflammation and Neurodevelopment in Children.

Authors:  Martha Scott Tomlinson; Kun Lu; Jill R Stewart; Carmen J Marsit; T Michael O'Shea; Rebecca C Fry
Journal:  Clin Microbiol Rev       Date:  2019-05-01       Impact factor: 26.132

3.  Inflammatory predictors of neurobehavior in very preterm infants.

Authors:  Marliese Dion Nist; Rita H Pickler; Tondi M Harrison; Deborah K Steward; Abigail B Shoben
Journal:  Early Hum Dev       Date:  2020-05-22       Impact factor: 2.079

4.  Chorioamnionitis in Rats Precipitates Extended Postnatal Inflammatory Lymphocyte Hyperreactivity.

Authors:  Tracylyn R Yellowhair; Shahani Noor; Brittney Mares; Clement Jose; Jessie C Newville; Jessie R Maxwell; Frances J Northington; Erin D Milligan; Shenandoah Robinson; Lauren L Jantzie
Journal:  Dev Neurosci       Date:  2019-03-28       Impact factor: 2.984

5.  Executive Dysfunction Early Postnatal Biomarkers among Children Born Extremely Preterm.

Authors:  Alan Leviton; Robert M Joseph; Raina N Fichorova; Elizabeth N Allred; H Gerry Taylor; T Michael O'Shea; Olaf Dammann
Journal:  J Neuroimmune Pharmacol       Date:  2018-09-06       Impact factor: 4.147

6.  The Relationship of Maternal Prepregnancy Body Mass Index and Pregnancy Weight Gain to Neurocognitive Function at Age 10 Years among Children Born Extremely Preterm.

Authors:  Elizabeth T Jensen; Jelske W van der Burg; Thomas M O'Shea; Robert M Joseph; Elizabeth N Allred; Tim Heeren; Alan Leviton; Karl C K Kuban
Journal:  J Pediatr       Date:  2017-03-21       Impact factor: 4.406

7.  Antenatal and neonatal antecedents of learning limitations in 10-year old children born extremely preterm.

Authors:  Alan Leviton; Robert M Joseph; Elizabeth N Allred; T Michael O'Shea; Karl K C Kuban
Journal:  Early Hum Dev       Date:  2018-02-07       Impact factor: 2.079

8.  Sex-Specific Genetic Susceptibility to Adverse Neurodevelopmental Outcome in Offspring of Pregnancies at Risk of Early Preterm Delivery.

Authors:  Michael W Varner; Maged M Costantine; Kathleen A Jablonski; Dwight J Rouse; Brian M Mercer; Kenneth J Leveno; Uma M Reddy; Catalin Buhimschi; Ronald J Wapner; Yoram Sorokin; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall Carpenter; Mary J O'sullivan; Alan M Peaceman; Donald J Dudley; Steve N Caritis
Journal:  Am J Perinatol       Date:  2019-02-07       Impact factor: 1.862

9.  In Utero Exposure to Histological Chorioamnionitis Primes the Exometabolomic Profiles of Preterm CD4+ T Lymphocytes.

Authors:  Poojitha Matta; Stacy D Sherrod; Christina C Marasco; Daniel J Moore; John A McLean; Joern-Hendrik Weitkamp
Journal:  J Immunol       Date:  2017-09-25       Impact factor: 5.422

10.  Systemic inflammation on postnatal days 21 and 28 and indicators of brain dysfunction 2years later among children born before the 28th week of gestation.

Authors:  Alan Leviton; Elizabeth N Allred; Raina N Fichorova; Karl C K Kuban; T Michael O'Shea; Olaf Dammann
Journal:  Early Hum Dev       Date:  2015-12-28       Impact factor: 2.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.